DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Guo D, Prins RM, Dang J. et al.
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.
Sci Signal 2009;
2 (101) ra82
Access:
We do not assume any responsibility for the contents of the web pages of other providers.